Cardiovascular Fixed Dose Combination Pill: A Pharmacodynamic Study of a Fixed Dose Combination of Acetylsalicylic Acid, Simvastatin, and Ramipril in Subjects With Elevated LDL Cholesterol.

Trial Profile

Cardiovascular Fixed Dose Combination Pill: A Pharmacodynamic Study of a Fixed Dose Combination of Acetylsalicylic Acid, Simvastatin, and Ramipril in Subjects With Elevated LDL Cholesterol.

Discontinued
Phase of Trial: Phase II

Latest Information Update: 30 Aug 2012

At a glance

  • Drugs Aspirin/ramipril/simvastatin; Simvastatin
  • Indications Hyperlipidaemia
  • Focus Therapeutic Use
  • Most Recent Events

    • 11 Apr 2012 Actual patient number is 36 according to ClinicalTrials.gov.
    • 11 Jul 2011 Planned end date changed from 1 May 2011 to 1 Mar 2011 as reported by ClinicalTrials.gov.
    • 11 Jul 2011 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top